Finch Therapeutics Group

Finch Therapeutics Group is a biopharma company developing therapeutics through the human microbiome in a human-first discovery platform.Theplatform. The company currently has an ongoing Phase 2 FDA clinical trial for recurrent C. difficile infection.

Patents solely owned by Finch:

Crestovo LLC, now known as Finch, is a clinical-stage microbiome therapeutics company that is leveraging its Human-First Discovery platform to create a novel class of orally administered biological drugs.

Crestovo LLC, now known as Finch, is a clinical-stage microbiome therapeutics company that is leveraging its Human-First Discovery platform to create a novel class of orally administered biological drugs.